Catamaran Slides as Analyst Suggests Cigna May Keep Unit

Catamaran Corp., the fourth-biggest drug-benefits manager, fell the most in almost a month after a Wedbush Securities report suggested the company may not have a chance to buy Cigna Corp.’s pharmacy plans.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.